Porton Newsletter | Q4 2024 Recap-Latest News and Updates from PORTON - Your Trusted CDMO Partner

CN
Home/Newsroom/News

News 2024-12-19

Porton Newsletter | Q4 2024 Recap

Others
More
Porton and Aojin Collaborate to Advance XDC Drugs for Dual INDs in China and U.S.

News 2024-12-11

Porton and Aojin Collaborate to Advance XDC Drugs for Dual INDs

Recently, Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. ("Aojin Life Sciences").
Porton shuitu Site block

News 2024-12-06

Porton Recognized as an Exemplary Case for Sustainable Development Among Chinese Listed Companies in 2024

Porton was recently selected as a "2024 Exemplary Case for Sustainable Development Among Chinese Listed Companies" by the China Association of Public Companies.
Become part of Porton' s community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2024 PORTON Legal Notices | Porton Privacy

This website contains information on products which are targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your countries. Please be aware that we do not take any responsibity for accessing suchinlomaon which may not compy wih anylegal process,regulaion,registraton or usage in the counry of your origin.

Become part of Porton' s community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2024 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200